Jamie Dimon on the bond market, Palantir contract: Trending Tickers
JPMorgan Chase & Co. (JPM) CEO Jamie Dimon warned that "a crack" is beginning to form in the bond market (^TYX, ^TNX, ^FVX) — "It is going to happen" — at an economic forum on Friday
The Trump administration has tapped Palantir Technologies (PLTR) for a new contract, according to the New York Times, to expand the government's tech infrastructure and databases.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Now time for some of today's trending tickers. We're looking at the 10-year Treasury. JP Morgan Chase CEO Jamie Diamond saying we're going to see a crack in the bond market. Diamond making the comments an economic form Friday, Josh. So Diamond saying issuing this warning, there's going to be a crack in the bond market. You're going to panic, he says. He says he's not going to panic, but you're going to panic. I might. Yeah, maybe you might maybe everybody will. Uh, it is Jamie Diamond and so obviously when he speaks people do pay attention and he's right to say that you stay focused on the bond market, which was spooking folks. And we can debate the reasons why, was it maybe it's debts and deficits or was it recession fears and widening, was it the selling in in Japanese government debt, but it was spooking folks.
There's something about Jamie Diamond and always hitting exactly where kind of the market zeitgeist is, right? It's if we're talking about the Fed and the Fed should cut seems to be the narrative that's out there, it feels like he starts talking about rates. If it's recession, it's that. Bond market has definitely been the conversation, right? And I think to Diamond's point, higher yields have weighed on stocks, right? That's been the clear trade over the last month in the sense that a lot of the broader market has struggled as rates are going higher and it definitely is feels like the biggest fear or one of the biggest fears in the market right now. City Stewart Kaiser laid out kind of three key risks to the bond or to the stock market and he said simply that premium that bond market premium continuing to move higher is one of the key risks he's concerned about right now.
And yet also hope though it does feel like things have perhaps right now calmed down a bit. I mean, I'm looking at the 10-year benchmark, we are back to 44.
Well, what I find interesting, he also said in this conversation that this may be the wake-up call that we need. I mean, I think with what we saw last two weeks, we got the wake-up call already. So I'm not really sure what this really adds. I mean, of course he's always going to make news with what he says, but you know, I I think he's already to your point talking about the zeitgeist and and we've been talking about it for a while. So, um, you know, to me it's it's always nice to have a Jamie headline here and there, but I'm just really not sure what new things we're learning from his insights today.
Yeah. I mean, he's he's right by me. I mean, debts and deficits are a big challenge and bond markets are going to have to navigate that. Yeah. We are checking in on Palantir by the way, those shares tacking on a nice 5% in today's trade. That's after the New York Times report of President Trump has expanded the software company's work across the federal government, tapping the company's technology, which can which can easily organize, we know and analyze data pulled from different agencies. So this was the Times report how the Trump administration has expanded Palantir's work, Josh, with the government. They say the company has received more than 113 million in federal government spending since Trump took office. Does not and that doesn't include by the way, they say this nearly $800 million contract the DOD awarded Alex Karp's company last week. This has not been a stock by the way you want to bet against. It's been rough.
No, short sellers have lost over two billion dollars betting on this stock since April 8th. That's from S3 partners, Josh. But you just zoom out on the stock like we're doing right now, right? You look over six months, things up 91%. Like stock is now trading at basically an all-time high, right?
Up 470% of the past 12 months.
Yeah, it's it's a crazy, crazy chart. And I think I was when we were talking about this before the show, I was looking stock was only up 1% and I was like, okay, maybe we finally just maxed out on potential catalyst here because it is a good contract. And the stock wasn't moving that much. Now interesting is we get the broader market rally that we're starting to see into the close. Palantir's one of the key movers. Palantir feels like it's been a little bit of a leader for the market. Palantir kind of moves a little bit higher than the market's moving, but it's definitely one of those hype trades.
But what do you make of it?
Palantir, Nvidia, these are companies you don't bet against now. I think what's most fascinating to me is that there were some concerns that defense stocks were going to get hit as the DOD operation was well underway and the fact that Palantir has done better than most expected, but clearly still winning more contracts and that Trump is is very much leaning into Karp's business is is obviously another reason that you will not now bet against Palantir.
And by the way, what else happened this week? Fannie Mae told us they're launching this AI powered crime detection unit. Who do they partner with?
Palantir.
Palantir.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Job market is holding its breath amid tariff truce with China
Job openings and hiring increased slightly in April ahead of the Friday employment report from the Labor Department, which will be a major data point for the Federal Reserve as it determines the path for interest rates that undergird economic activity. Like other economic factors, including capital expenditures and consumer spending levels, employment conditions are in a holding pattern as companies wait to see where U.S. tariff policy lands amid President Trump's ongoing trade war and his fragile truce with top trading partner China. Job openings increased to 7.4 million in April from 7.2 million in March, according to data released Tuesday. New hires increased by about 170,000, while separations also increased, with about 100,000 workers leaving their roles. While many sectors reported fewer job openings in April, bigger industries including professional services and health care more than made up for the reductions in the smaller sectors. Job openings have been fluctuating between 7 million and 8 million per month for about a year now, after descending rapidly off a postpandemic high around 12 million. There's now one open job for every job seeker in the economy. The rate of people quitting their jobs — viewed informally as a general measure of job security — decreased slightly to 2.0 percent in April from 2.1 percent in March as a share of total employment, while contracting by 0.1 percent compared to last year. The quits rate has remained within a 0.1-point range of 2.0 percent since May 2024. Economists are seeing the modest variation in the context of increased policy uncertainty. 'Modest gains in job openings and layoffs suggest that employers are proceeding cautiously with headcount decisions despite elevated uncertainties about the economy and policy,' wrote Noah Yosif, economist with the American Staffing Association, in a Tuesday commentary. Trump summoned Fed Chair Jerome Powell for a meeting last week as the president's negotiations continue. Many economists, including those in the Fed, have been predicting higher inflation as a result of Trump's tariffs, and Trump has been telling Powell to lower interest rates to support the economy. This comes even as inflation has been falling in recent months, dropping to a 2.1 percent annual increase in the April personal consumption expenditures (PCE) price index — close to the Fed's target rate of 2 percent. Powell said in May he's looking for indications unemployment could rise in response to Trump's tariffs. 'I am watching for signs that the labor market could cool as tariff increases begin to weigh on economic activity,' he said. Hiring within small businesses is also in a holding pattern. Job growth as measured in the Paychex Small Business Employment Watch held steady across May and April, delivering flat employment growth since the beginning of the year. 'Despite the rapidly changing news cycle, the underlying labor market remains fundamentally healthy,' Paychex CEO John Gibson said Tuesday in a statement. Many economists are viewing the employment situation, along with many other economic variables, as a direct consequence of developing White House trade policies. China and the U.S. paused triple-digit tariffs on each other last month, which brought the overall U.S. tariff level down from around a century-high 25 percent and closer to 15 percent. This improved many economic forecasts. Revisions by Deutsche Bank to predictions made in April showed lower unemployment and inflation, and revisions for growth were higher. 'The key innovation to the outlook over the past month has been a quicker de-escalation in trade tensions, particularly with China,' analysts for the bank wrote in a Monday note to investors. Despite the trade détente with China, tensions flared this week as both sides traded barbs. 'The bad news is that China, perhaps not surprisingly to some, has totally violated its agreement with us. So much for being Mr. Nice Guy!' Trump wrote on his social media website on Friday. China on Monday said the U.S. violated the deal by issuing export control guidelines for artificial intelligence hardware, stopping chip-design software to China, and revoking Chinese student visas. In its statement, the Chinese Ministry of Foreign Affairs accused the U.S. of unilaterally provoking new economic and trade frictions. Despite the accusations and targeted actions, neither country reimposed its triple-digit tariffs. In the minutes of their latest meeting to set interest rates — which notably took place before the trade truce was announced on May 12 — Fed bankers saw unemployment rising 'substantially' through the end of the year in the context of trade policy. 'The labor market was expected to weaken substantially, with the unemployment rate forecast moving above the staff's estimate of its natural rate by the end of this year and remaining above the natural rate through 2027,' the minutes for the May 6 meeting read. Economists say the Friday jobs report will show if employers are feeling positive or negative about the economic and policy outlook. 'Should Friday's jobs report reveal a significant contraction in non-farm payroll growth relative to its three-month average, it would confirm employers are adopting a more pessimistic outlook toward future headcount decisions,' Yosif wrote. Bankrate economic analyst Mark Hamrick said he expected 125,000 jobs to be added to the economy in the May report and that the unemployment rate would hold steady at 4.2 percent, where it is now. 'Despite ongoing uncertainties from tariffs and broader economic volatility, new unemployment claims have remained relatively restrained,' he observed in a Tuesday analysis, adding that the Fed would 'continue in 'wait and see' mode' when it came to upcoming interest rate decisions. As employment conditions and other economic variables have been held in abeyance during the trade reset, wage growth has been moderating, dropping to a 3.77 percent increase from 3.83 percent in March, off a recent high of 4.15 percent in November of last year. Total inflation-adjusted hourly compensation was flat in the first quarter after falling to a 1.2 percent increase in the fourth quarter of last year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
HeartCore Signs 15th Go IPO Contract
NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ('HeartCore' or the 'Company'), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement ('Consulting Agreement') with tmsuk Co. Ltd. ('tmsuk') for its 15th Go IPO consulting service win. As compensation for its services, tmsuk will pay HeartCore an aggregate of $500,000 in fees, and issue to HeartCore a warrant to acquire 3% of tmsuk's capital stock, on a fully diluted basis. The warrant, which is fully earned, vested, and non-returnable, may be subject to approval by tmsuk's shareholders; if such approval is not obtained, and the warrant is not issued, within 90 days, the parties agreed to cooperate to agree on an alternative arrangement of equivalent value and rights. 'Even with the ongoing uncertainty of the IPO market, we continue to see steady interest in our Go IPO services from Japanese growth companies,' said HeartCore CEO Sumitaka Kanno. 'With our first Go IPO contract secured for the year, we remain cautiously optimistic about our pipeline and are actively engaged in several early-stage discussions with other companies exploring a U.S. exchange listing. In September 2025, we will host our first South Korea Go IPO seminar, aimed at expanding Go IPO's presence beyond Japan and adding to our growing pipeline. With a few clients nearing the final stages of their IPO process, we look forward to guiding them through to completion this year.' As part of the Consulting Agreement, HeartCore agreed to assist tmsuk in its efforts to go public and list on the Nasdaq Stock Market ('Nasdaq'). Through Go IPO, the Company services clients by assisting throughout the underwriter, audit, and legal firm hiring process, translating requested documents into English, assisting in the preparation of documentation for internal controls required for an initial public offering or de-SPAC or other fundamental transactions, conversion of accounting data from Japanese standards to U.S. GAAP, creation of an English web page, preparation of an investor presentation and executive summary of the Company's operations, provision of providing general support services, assisting in the preparation of an S-1 or F-1 filing, and more. About HeartCore Enterprises, in Tokyo, Japan, with offices in New York and San Francisco, CA, HeartCore is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore's customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore's Go IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company's products and services is available at Forward-Looking StatementsAll statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as 'believed,' 'intend,' 'expect,' 'anticipate,' 'plan,' 'potential,' 'continue,' or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore's filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore's control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore's current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein. HeartCore Investor Relations Contact:Gateway Group, Glover and John YiHTCR@ 574-3860Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers
Hims & Hers Health (HIMS) announced it will be acquiring European telehealth platform Zava in an all-cash deal. The stock is falling ahead of Tuesday's market close. Credo Technology (CRDO) shares surge after beating fiscal fourth quarter earnings and revenue estimates. Kenvue (KVUE) shares move to the downside after CEO Tebow Mongeau pointed to certain seasonal challenges this summer at a conference. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. It's time for today's trending tickers. We're watching Hims and Hers Health, Credo Technology, both on the up and up today, as well as Kenvue, which is going in the upper other direction. Starting off with Hims, it's having a rocky day today despite announcements that the company would be acquiring Zava, a European health platform. Him's stock hit some gains when trading opened, but then we saw it turning lower as the morning progressed, so the stock right now down by more than 3%. Most of the analysts have been pretty positive on this one. I did see an interesting note from Allen Letz over at Bank of America, which has an underperform on the stock, and they said, you know, mixed reaction to this. They said this is positive here, but on the negative side, they say if you look at other US healthcare tech companies that have moved into Europe, it hasn't worked out so well. Yeah, I see analysts at uh quoting saying, "On paper, the tie-up makes sense," because they're talking about how Zava offers the same products and services that Hims currently does, also some uh some areas that are on its growth roadmap that call for example, hormone replacement therapy, but they they do see some execution and integration risks. They do call the stock, by the way, they've been on a move already. Something like 100% this year. Yeah, it's been on fire. On fire. All right, Credo Technology. Let's check out that one as well. It's going in the opposite today after the company reported a 400% increase in earnings and 180% increase in sales on a year-to-year basis, leading to huge stock market gains for Credo. So revenue for the fourth quarter, I did see that beat estimates. Revenue was 170 million. It looks like consensus was close to around 160. I see Barclays is saying this is the company's second material beat and raise. Uh this one features, they noted, three large customers versus Amazon alone. Says it's a rare combination of small scale with big tech. Barclays is a buy. By the way, so is buy, so is every single analyst on the street. All 13 buys. Wow! Yeah. A lot of excitement around this company. So networking company, the CEO on the conference call saying, um I think all of the hyperscalers have the potential to be a 10% customer long term. Now, right now, according to Needham estimates, Microsoft accounts for about 12%, XAI accounts for about 11%, um Amazon, it's very reliant on Amazon, 61% of its business last quarter. So I guess if they get less reliant on one client and sort of ever all of these huge hyperscalers are each spending at least 10% with them, I guess analysts think that's a pretty good place to be. And plenty do. It is one of the places to be. Yeah. Seems that way. And let's look at Kenvue. Those shares are seeing some losses after the company CEO, Thibaut Mongon expressed seasonal demand is behind last year's for the company. It's even behind the company's own expectations. He made some comments at a um at a conference today. He said, "It's not a great year so far for allergy and the sun category is more or less the same." By the way, Kenvue, it's not known under its brand name, but it is, if you remember, it spun off in 2023 from Johnson & Johnson. So it has like the consumer-facing brands that had been under J&J. Yeah, consumer products company. Yeah. So this is, they make this presentation, um and the CEO apparently, so he warns about the seasonal demand, as you said, he's uh talked about being behind last year, its own expectations. I mean, not surprisingly, investors reacting. He says, "Not a great year so far for allergy." Uh the sun category more or less the same. On the consumer, making some comments there that were interesting. You're always looking for, you know, what executives are saying and any kind of line of sight you can have into the consumer. Uh this CEO saying, "We definitely see the consumer continuing to be under pressure, regardless of the geography, for slightly different reasons." Interesting. I mean, all of that said, the stock is up about 4% this year. It's up about 15% over the past year. Um most analysts have holds on this thing. There are 15 holds and four buys. As I mentioned, it spun off from J&J back in August of 2023. Kenvue shares are down about round 6% since then. It's interesting. Johnson & Johnson shares are about down about the same amount. So it's not as though the spin-off, you know, caused either one of them to outperform the other.